M 1918 L-Valine |
|
(CH3)2CHCH(NH2)COOH | |
Delivered ≥ 95% pure with dated HPLC UV chromatogram | |
Solid | |
1 mg $215 | |
Screw cap v-vial | 5 mg $565 |
M.W. 117.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 277 L-Valine, [14C(U)]- Click here for Typical Certificate of Analysis |
|
(CH3)2CHCH(NH2)COOH | |
MORpure Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
Ethanol:water (2:98) solution, 100 µCi/ml | 50 µCi (1.85 MBq) $3970 |
> 180 mCi(6.7 GBq)/mmol | 250 µCi (9.25 MBq) $5215 |
NextGen V-Vial | |
M.W. 117.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 1133 L-Valine, [1-14C]- Click here for Typical Certificate of Analysis |
|
(CH3)2CHCH(NH2)COOH | |
MORpure Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
0.01N HCl solution, 100 µCi/ml | 50 µCi (1.85 MBq) $3970 |
> 45 mCi(1.665 GBq)/mmol | 250 µCi (9.25 MBq) $5700 |
NextGen V-Vial | |
M.W. 117.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 1383 D-Valine, [1-14C]- |
|
(CH3)2CHCH(NH2)COOH | |
MORpure Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
0.01N HCl solution, 100 µCi/ml | 50 µCi (1.85 MBq) $3970 |
> 45 mCi(1.665 GBq)/mmol | 250 µCi (9.25 MBq) $4840 |
NextGen V-Vial | |
M.W. 117.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1654 L-Valine, [3H]- Click here for Typical Certificate of Analysis |
|
(CH3)2CHCH(NH2)COOH | |
MORpure Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
Ethanol:water (2:98) solution, 1 mCi/ml | |
> 0.5 Ci(18.5 GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
NextGen V-Vial | 1 mCi (37 MBq) $2100 |
M.W. 117.15 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |